Idioma:

Effectiveness and safety of cyclosporine in pediatric plaque psoriasis: A multicentric retrospective analysis

Di Lernia, V. ; Stingeni, L. ; Boccaletti, V. ; Calzavara Pinton, P. G. ; Guarneri, C. ; Belloni Fortina, A. ; Panzone, M. ; Corazza, M. ; Neri, I. ; Cambiaghi, S. ; Lasagni, C. ; Ficarelli, E. ; Gisondi, P.

The Journal of dermatological treatment, 2016-10, Vol.27 (5), p.395-398 [Periódico revisado por pares]

England: Taylor & Francis

Texto completo disponível

Citações Citado por

Enviar para

Título:
Effectiveness and safety of cyclosporine in pediatric plaque psoriasis: A multicentric retrospective analysis
Autor: Di Lernia, V. ; Stingeni, L. ; Boccaletti, V. ; Calzavara Pinton, P. G. ; Guarneri, C. ; Belloni Fortina, A. ; Panzone, M. ; Corazza, M. ; Neri, I. ; Cambiaghi, S. ; Lasagni, C. ; Ficarelli, E. ; Gisondi, P.
Assuntos: Adolescent ; Child ; childhood ; cyclosporine ; Cyclosporine - therapeutic use ; Female ; Humans ; Immunosuppressive Agents - therapeutic use ; Italy ; Male ; Psoriasis ; Psoriasis - drug therapy ; Retrospective Studies ; therapy ; treatment ; Treatment Outcome
É parte de: The Journal of dermatological treatment, 2016-10, Vol.27 (5), p.395-398
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: Background: Cyclosporine (CysA) is effective for psoriasis in adult patients but little data exist about its efficacy and safety in childhood and adolescence psoriasis. Objectives: To assess the effectiveness and safety of CysA for childhood and adolescence psoriasis. Methods: Retrospective analysis of a group of children and adolescents (age < 17 years) with plaque psoriasis treated with CysA at several Italian dermatology clinics. Results: Our study population consisted of 38 patients. The median age at the start of treatment was 12.3 years. Therapy duration varied from one to 36 months. The median maintenance dosage per day was 3.2 mg/kg (range 2-5 mg/kg). Fifteen patients (39,4%) achieved a complete clearance or a good improvement of their psoriasis defined by an improvement from baseline of ≥75% in the psoriasis area and severity index (PASI) at week 16. Eight patients (21.05%) discontinued the treatment due to laboratory anomalies or adverse events. Serious events were not recorded. Conclusions: In this case series, CysA was effective and well-tolerated treatment in a significant quote of children. CysA, when carefully monitored, may represent a therapeutic alternative to the currently used systemic immunosuppressive agents for severe childhood psoriasis.
Editor: England: Taylor & Francis
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Effectiveness and safety of cyclosporine in pediatric plaque psoriasis: A multicentric retrospective analysis

Di Lernia, V. ; Stingeni, L. ; Boccaletti, V. ; Calzavara Pinton, P. G. ; Guarneri, C. ; Belloni Fortina, A. ; Panzone, M. ; Corazza, M. ; Neri, I. ; Cambiaghi, S. ; Lasagni, C. ; Ficarelli, E. ; Gisondi, P.

England: Taylor & Francis

Buscando em bases de dados remotas. Favor aguardar.